Table 2 Characteristics of the prescriptions in the first year after index date
Treatment (no. of users) | No. of scripts | No. of scripts per patient | Average quantity per script (SD) | Average duration per script in days (SD) | Median duration per script in days |
|---|---|---|---|---|---|
Asacol® and generics (699) | 5994 | 8.6 | 146 (102) | 24.0 (12.8) | 30 |
Pentasa® (208) | 1627 | 7.8 | 111.7 (92.9) | 19.8 (12.7) | 30 |
Salofalk® (817) | 7317 | 9.0 | 140.0 (96.8) | 23.0 (14.1) | 30 |
Mezavant® (147) | 2124 | 14.4 | 77.1 (40.5) | 27.2 (11.7) | 30 |